Forefront Analytics’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,827
Closed -$237K 70
2021
Q2
$237K Sell
2,827
-140
-5% -$11.5K 0.09% 51
2021
Q1
$226K Sell
2,967
-267
-8% -$19.4K 0.1% 51
2020
Q4
$220K Buy
+3,234
New +$210K 0.1% 53
2020
Q2
Sell
-22
Closed -$1.3K 74
2020
Q1
$1.3K Buy
+22
New +$1.47K ﹤0.01% 118

Other funds holding CVS

Forefront Analytics's CVS Position: Q3 2021 in Review

Forefront Analytics sold out of CVS Health (CVS) in Q3 2021, closing a stake of 2,827 shares — an estimated $237K sold.

Forefront Analytics first reported a position in CVS in Q1 2020 and held it in 4 quarters. The position peaked at $237K in Q2 2021. 2,072 funds tracked by Wall St. Rank hold CVS as of Q3 2021.

  • Forefront Analytics reported no remaining CVS Health position as of Q3 2021 after selling out during the quarter.
  • Forefront Analytics sold 2,827 CVS Health shares in Q3 2021, an estimated $237K.
  • Forefront Analytics first reported a position in CVS Health in Q1 2020 and held it in 4 quarters.
  • Forefront Analytics's CVS Health position peaked at $237K in Q2 2021.
  • 2,072 funds tracked by Wall St. Rank held CVS Health as of Q3 2021.

Based on Forefront Analytics's 13F filing for Q3 2021, filed 15 Nov 2021.